Quantcast

Frost & Sullivan Recognizes Doxa AB for Ceramir(TM) Crown & Bridge – Its Pioneering Biocompatible Dental Cement

February 11, 2010

LONDON, Feb. 11 /PRNewswire/ — Based on its recent research on the dental devices market, Frost & Sullivan presents Doxa AB with the 2010 European Frost & Sullivan Award for New Product Innovation of the Year for its Ceramir(TM) Crown & Bridge, a dental cement. The first of its kind, Doxa’s product is based on the unique Ceramir technology that is developed by nano-structurally integrating bioceramics.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Dental procedures have been in a rise due to the lack of proper care for the teeth. Simultaneously, the need for newer biomaterials with a better compatibility with the human body has become more obvious. Lack of biocompatibility directly links to increase in pain for the patient and the need to repeat the procedure, which increases the healthcare expenditure. This can be avoided with better biocompatibility of the biomaterial used for treating dental disorders.

Interestingly the need for tooth filling and denture fixing is due to secondary caries that are caries found in the restored tooth. In normal cements, there is a crevice formed between the material and dental tissue, where the risk of leak of nutrients and bacteria is high. This leads to decay of the tooth in the long run. The reasons for the gap formation may be many, depending on the type of material used, but can be attributed to physical change of the material when exposed to heat and other factors.

“The materials in the mouth are exposed to heat, rapid change in temperatures, mechanical loads and bacterial influx, hence the material used should be of very high resistance to prevent gradation with time, and reduce changes inflicted to the natural environment,” says Frost & Sullivan Senior Research Analyst Sowmya Rajagopalan. “The need for addressing these drawbacks directly links to increased biocompatibility that is the key feature of Doxa’s Ceramir(TM) Crown & Bridge, which has the special ability to thrive with saliva and heat.”

A chemical curing reaction starts when water is mixed with the ceramic powder and nano-crystals precipitate. These crystals adhere to all surfaces and thus integrate better with the tooth. This hardening mechanism of the material is unique. It helps fill the contact zone between the tooth and the foreign material, thus increasing biocompatibility.

One of the key benefits of Ceramir(TM) Crown & Bridge, other than increased biocompatibility, is the ability to have quicker treatment procedure. The product is designed such that the material, cement powder and the liquid activating the cement, come in a capsule. Ceramir(TM) Crown & Bridge is the only bioceramic which hardens effectively at body temperature. Even the packaging is made of recyclable materials with small amount of packaging material to be environment friendly.

“Ceramir(TM) Crown & Bridge can coexist in a natural environment – it does not shrink and has thermal properties close to the enamel and dentine,” says Rajagopalan. “The resulting treatment, reduced pain and increased success rates of the implantation reflects on the health statistics with reduced repeat dental procedures and decrease in healthcare expenditure.”

Over the whole of last year, the awareness and acceptance of Ceramir(TM) Crown & Bridge has been steadily increasing. For revolutionizing the dental cements Industry, Doxa is the worthy recipient of the 2010 European Frost & Sullivan Award for New Product Innovation of the Year. Each year, Frost & Sullivan presents this award to a company that has demonstrated and innovative element in a product by leveraging leading edge technologies. The award recognizes the benefits of the product, its increased value for customers and the resulting rise in customer acquisition/penetration potential.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Doxa AB

Doxa is a Swedish dental company founded in 1987 that produces dental product based on Bioceramics. The company’s focus has been on the research and development of Bioceramics for use within orthopaedics and odontology and Doxa is today a world leader in the development of bioactive ceramics and its proprietary technology has been reviewed in more than 60 publications. During the years Doxa has had a close contact with Uppsala University.

In 2009, Doxa reorientated the focus of its activities and took the step from being a development company to that of a dental marketing and sales organisation. With the patient in focus, Doxa aims at developing dental materials which are user-friendly, biocompatible and environmentally friendly.

Ceramir(TM) Crown & Bridge is the first product in a series of planned dental Bioceramics products from Doxa. The Ceramir(TM) Crown & Bridge is used for permanent cementation during the dental procedures. The product was launched in 2009. To read more about the product, please visit http://www.ceramir.se.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.awards.frost.com.


    Contact:

    Catherine Brassell
    Best Practices
    Frost & Sullivan
    catherine.brassell@frost.com
    ----------------------------
    P: +44.207.915.7867

SOURCE Frost & Sullivan


Source: newswire



comments powered by Disqus